“My philanthropic efforts are largely directed towards making a difference to global healthcare especially in the developing world,” Mazumdar-Shaw said in her pledge letter. “I am particularly concerned about the unbearable financial burden that debilitating diseases like cancer impose on patients in poor countries. I am also conscious of the fact that two-thirds of the world’s population has little or no access to an acceptable quality of healthcare.” Mazumdar-Shaw said she grew up in a middle class family in India and was taught that wealth creation is about making a difference to society. “As a first generation entrepreneur, I built my company Biocon with these guide principles,” she said. “My success with Biocon has given me the wherewithal to pursue my overachieving commitment to social inclusiveness.” The biopharmaceutical leader is using her philanthropic efforts by adopting a large number of primary health centers in rural India to transform them into telemedicine and technology-enabled centers that “can bridge the deficit of medical resources.”
She has also created a large affordable cancer center — the Mazumdar-Shaw Center for Translational Research — a 1,400-bed facility in partnership with Dr. Devi Shetty.